Registered entities
Seelos Therapeutics, Inc.
Reg. No. 87-0449967001United States
APRICUS BIOSCIENCES, INC.
Reg. No. 1017491United States
Innovation
11 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 1,724 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 2 |
Investor mix
3 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 33% |
| Other / undisclosed | 2 | 67% |